Topology and DNA breaks Group

Home | Research & Innovation | Scientific Programmes | Molecular Oncology Programme | Topology and DNA breaks Group

Research Scientists

  • Israel Salguero
  • Angélica Santiago

Post-Doctoral Fellows

  • Héctor Díaz

Graduate Students

  • Marina Bejarano
  • Alba de Haro
  • Ernesto López
  • María del Mar Martínez
  • Javier Montes

Technicians

  • Aicha El Bakkali

We have a general interest in understanding how DNA topoisomerase activity is regulated to integrate different aspects of genome dynamics, how an imbalance in these processes can lead to the appearance of pathological DNA breaks, and how cells specifically respond to these lesions to maintain genome stability. In this sense, topoisomerase-induced DNA breaks are emerging as important drivers of oncogenic transformation. Moreover, since drugs that target topoisomerase activity are widely used chemotherapeutic agents, our discoveries have direct implications in cancer treatment.

Recently, we opened a new research line aimed at developing novel methods for sequence-specific nucleic-acid detection based on CRISPR-Cas technology, with the idea of producing sensitive and versatile genetic diagnostic kits and devices that can be implemented in a point-of-care setting.

Publications

Up

CNIO
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.